title: Cannabidiol inhibits synaptic transmission in rat hippocampal cultures and slices via multiple receptor pathways.
abstract: OBJECTIVE
  Cannabidiol (CBD) has emerged as an interesting compound with therapeutic potential in several CNS disorders. However, whether it can modulate synaptic activity in the CNS remains unclear. Here, we have investigated whether CBD modulates synaptic transmission in rat hippocampal cultures and acute slices.
  
  
  METHODS
  The effect of CBD on synaptic transmission was examined in rat hippocampal cultures and acute slices using whole cell patch clamp and standard extracellular recordings respectively.
  
  
  RESULTS
  Cannabidiol decreased synaptic activity in hippocampal cultures in a concentration-dependent and Pertussis toxin-sensitive manner. The effects of CBD in culture were significantly reduced in the presence of the cannabinoid receptor (CB(1) ) inverse agonist, LY320135 but were unaffected by the 5-HT(1A) receptor antagonist, WAY100135. In hippocampal slices, CBD inhibited basal synaptic transmission, an effect that was abolished by the proposed CB(1) receptor antagonist, AM251, in addition to LY320135 and WAY100135.
  
  
  CONCLUSIONS
  Cannabidiol reduces synaptic transmission in hippocampal in vitro preparations and we propose a role for both 5-HT(1A) and CB(1) receptors in these CBD-mediated effects. These data offer some mechanistic insights into the effects of CBD and emphasize that further investigations into the actions of CBD in the CNS are required in order to elucidate the full therapeutic potential of CBD.
authors.affiliation: Strathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, UK.
authors.forename: C J
authors.initials: CJ
authors.lastname: Ledgerwood
authors.forename: S M
authors.initials: SM
authors.lastname: Greenwood
authors.forename: R R
authors.initials: RR
authors.lastname: Brett
authors.forename: J A
authors.initials: JA
authors.lastname: Pratt
authors.forename: T J
authors.initials: TJ
authors.lastname: Bushell
mesh_terms: D000818:Animals; D002185:Cannabidiol / Q000494:pharmacology*; D002478:Cells, Cultured; D006624:Hippocampus / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D066298:In Vitro Techniques; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D043882:Receptors, Cannabinoid / Q000378:metabolism*; D009435:Synaptic Transmission / Q000187:drug effects*
chemical_list: D043882:Receptors, Cannabinoid; D002185:Cannabidiol
references.citation: J Ethnopharmacol. 2006 Apr 21;105(1-2):1-25
references.pmid: 16540272
references.citation: J Pharmacol Exp Ther. 2008 Jun;325(3):1007-15
references.pmid: 18354058
references.citation: Science. 1994 Apr 1;264(5155):107-11
references.pmid: 7832825
references.citation: Br J Pharmacol. 2008 Jan;153(2):199-215
references.pmid: 17828291
references.citation: Psychopharmacology (Berl). 2008 Aug;199(2):223-30
references.pmid: 18446323
references.citation: Neuropsychopharmacology. 2008 Sep;33(10):2505-16
references.pmid: 18185500
references.citation: J Neurosci Res. 2009 Feb 15;87(3):766-75
references.pmid: 18816788
references.citation: Cell Calcium. 2005 Sep-Oct;38(3-4):369-74
references.pmid: 16085309
references.citation: Annu Rev Cell Dev Biol. 2000;16:521-55
references.pmid: 11031246
references.citation: Br J Pharmacol. 2010 Jan;159(1):122-8
references.pmid: 20002102
references.citation: Br J Pharmacol. 2009 Nov;158 Suppl 1:S1-254
references.pmid: 19883461
references.citation: Neuropsychopharmacology. 2010 Feb;35(3):764-74
references.pmid: 19924114
references.citation: Expert Opin Pharmacother. 2010 Jan;11(1):17-31
references.pmid: 20001426
references.citation: Mol Pharmacol. 2009 Apr;75(4):892-900
references.pmid: 19118122
references.citation: Med Hypotheses. 2006;66(2):234-46
references.pmid: 16209908
references.citation: J Biol Chem. 2008 Jun 6;283(23):16124-34
references.pmid: 18390906
references.citation: Cell Calcium. 2002 Nov-Dec;32(5-6):405-11
references.pmid: 12543099
references.citation: Trends Pharmacol Sci. 2009 Oct;30(10):515-27
references.pmid: 19729208
references.citation: J Pharmacol Exp Ther. 2000 Mar;292(3):960-7
references.pmid: 10688610
references.citation: J Neurosci. 1995 Nov;15(11):7217-25
references.pmid: 7472476
references.citation: J Physiol. 2005 Dec 1;569(Pt 2):501-17
references.pmid: 16179366
references.citation: Neurochem Res. 2005 Aug;30(8):1037-43
references.pmid: 16258853
references.citation: Br J Pharmacol. 2007 Mar;150(5):613-23
references.pmid: 17245363
references.citation: Mol Pharmacol. 1999 Jan;55(1):8-13
references.pmid: 9882692
references.citation: Hippocampus. 2007;17(4):316-25
references.pmid: 17330864
references.citation: J Neurosci. 2008 Jun 11;28(24):6231-8
references.pmid: 18550765
references.citation: J Biol Chem. 2007 Sep 7;282(36):26235-44
references.pmid: 17616519
references.citation: Trends Cogn Sci. 2006 Apr;10(4):167-74
references.pmid: 16531099
references.citation: Int J Neuropsychopharmacol. 2010 May;13(4):421-32
references.pmid: 19775500
references.citation: Br J Pharmacol. 2009 Jan;156(1):181-8
references.pmid: 19133999
references.citation: J Pharmacol Exp Ther. 2010 Feb;332(2):569-77
references.pmid: 19906779
references.citation: Mol Neurobiol. 1998 Winter;17(1-3):59-72
references.pmid: 9887446
references.citation: J Neurophysiol. 1994 Jun;71(6):2570-5
references.pmid: 7931538
references.citation: J Neurosci. 2007 Jan 31;27(5):1211-9
references.pmid: 17267577
references.citation: J Neurosci. 1988 Apr;8(4):1273-85
references.pmid: 2965756
references.citation: J Neurosci. 2009 Feb 18;29(7):2053-63
references.pmid: 19228959
references.citation: J Physiol. 1991 Dec;444:687-701
references.pmid: 1668353
references.citation: Life Sci. 2005 Feb 4;76(12):1307-24
references.pmid: 15670612
references.citation: Neuropharmacology. 2006 Apr;50(5):621-31
references.pmid: 16386766
references.citation: J Physiol. 1987 Dec;394:99-124
references.pmid: 3443977
references.citation: Br J Pharmacol. 2001 Oct;134(4):845-52
references.pmid: 11606325
references.citation: Arch Gen Psychiatry. 2009 Apr;66(4):442-51
references.pmid: 19349314
references.citation: J Pharmacol Exp Ther. 1996 Sep;278(3):989-99
references.pmid: 8819477
references.citation: Br J Pharmacol. 1998 May;124(1):93-100
references.pmid: 9630348
references.citation: J Neurosci. 2002 Jul 15;22(14):5840-7
references.pmid: 12122046